Well-Being in Melanoma Patients During COVID-19
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Recruiting
Observational Study
COVID-19 Infection
Melanoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,152 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Other
Who this trial is looking for
This trial is looking for melanoma patients to understand how the COVID-19 pandemic may have affected their health and quality of life. Participants will complete a 10-minute questionnaire about their experiences during the pandemic.
Are You a Good Fit for This Trial?
You may be able to join if
- I have signed consent for a previous study
- I have an active email address
- I can be contacted via MyChart
- I am documented as being alive per the cancer registry
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency fact…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who have signed consent for PA15-0336
* Has an active email address and can be contacted via MyChart
* Documentation of being alive per the cancer registry
Contacts